Intrusion Inc. enters its May 12 Q1 earnings report with a striking reversal: short sellers who had aggressively built positions over April have now retreated almost entirely, even as the stock keeps falling.
The sharpest story here is in short interest positioning. At its April peak, estimated short interest climbed above 440,000 shares — more than three times the current level of roughly 116,000 shares, a drop of 72% over the past week alone. That's not short covering on strength; the stock is down 11% on the week and 13% over the past month to $0.77. Shorts have withdrawn while the price has continued to drift lower, which points to mechanical de-risking rather than a squeeze. Cost to borrow has also eased, dropping 11% over the week to 1.39% and down nearly half from levels seen six weeks ago near 2.7%. The borrow market is well-supplied — availability runs at about 199% of short interest — meaning there is no meaningful friction for anyone wanting to rebuild a short position.
The ORTEX short score has tracked the unwind closely. It peaked near 52.6 in mid-April and has since fallen to 42.9, now sitting in only the 33rd percentile. Days-to-cover ranks in the 8th percentile, underscoring how thin the short position has become relative to the universe. Whatever bearish conviction drove the April accumulation has dissipated quickly.
The Street is sharply divided and the targets tell a blunt story. Two analysts cover — Ascendiant Capital holds a Buy with a $10.50 target (cut from $12.50 on April 9), while HC Wainwright sits at Neutral with a $1.00 target (cut in half at the end of March). The mean target of $5.75 is mathematically between two very different assessments of the company's value and deserves little weight on its own. The bull case centres on Intrusion's threat-intelligence platform gaining traction with enterprise clients and cloud partnerships, with the company targeting breakeven in 2026. The bear case is starker: revenue declining, balance sheet thin, and competition intensifying. With the stock near $0.77, even the Neutral analyst's $1.00 target implies meaningful upside — but the gap to the Buy target reflects a genuine disagreement about whether INTRUSION Shield can generate the contract wins needed to change the financial trajectory.
The earnings history adds a note of caution. The most recent print, on March 24, sent the stock down 13% on the day and 27% over the following five sessions. The prior event in February produced a milder 4% day-one drop but a 5% five-day loss. Neither reaction was punishing enough to explain the April short build, but both confirm the stock has not been rewarding holders around reporting dates. The May 12 Q1 release arrives against a backdrop of downward EPS estimate revisions, with Ascendiant's Q2 forecast recently reduced.
On the ownership side, Potomac Capital Management built a fresh 473,050-share position in Q4 2025, a notable new entry for a small-cap fund. Insider activity has been one-directional: the CFO and the founder-CTO both sold modest parcels in January at $1.30. The CEO last sold in August 2025. None of the transactions were large in dollar terms, but none represent buying conviction either.
The May 12 print is the next real test — the question will be whether Intrusion can show any revenue stabilisation against a quarter that carries lowered expectations from both analysts covering the name.
See the live data behind this article on ORTEX.
Open INTZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
